Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Rigetti Revises Quantum Computing Timeline, Prioritizing System Performance

Felix Baarz by Felix Baarz
January 14, 2026
in AI & Quantum Computing, Nasdaq, Tech & Software
0
Rigetti Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Rigetti Computing has announced a significant update to its development schedule, opting to delay the broader release of its next-generation quantum processor. The company’s new 108-qubit system, named Cepheus™‑1‑108Q, will now target general availability by the end of the first quarter of 2026, a shift from its earlier launch plan. This decision underscores a strategic pivot: emphasizing quality and precision over speed, even as the move may draw near-term skepticism from some market observers.

A Deeper Dive into the Schedule Change

On January 9, Rigetti formally updated its technology roadmap, pushing back the introduction timeline for its largest modular quantum processor to date. The delay is attributed to requirements for additional testing and optimization. Company leadership acknowledged meaningful progress but stated that internal quality benchmarks have not yet been fully met.

A primary technical challenge involves the complexity of “tunable couplers,” essential components that manage interactions between qubits. To address this, Rigetti has initiated another chip iteration cycle. The objective is to enhance overall system performance, with a specific focus on reducing error rates in two-qubit operations.

Performance Metrics Take Precedence

From a technical standpoint, Rigetti reports tangible advances. The current iteration of the 108-qubit system demonstrates a median two-qubit gate fidelity of 99%. However, the company’s internal target is more ambitious, aiming to elevate this figure to 99.5% before commercial release.

The firm’s capability is evidenced by its smaller-scale systems. Its 9-qubit processor achieves a median two-qubit fidelity of 99.7%, while the 36-qubit system reaches 99.6%. These results confirm the underlying technology’s potential; the core hurdle is replicating this high performance consistently on the much larger 108-qubit architecture.

Some market analysts view the revised schedule as a manageable setback. For instance, Wedbush Securities reaffirmed its “Outperform” rating on Rigetti shares on January 12, emphasizing that in the quantum computing sector, precision should rightly take precedence over a rushed launch.

Should investors sell immediately? Or is it worth buying Rigetti?

Industry Challenges and Investor Sentiment

This roadmap adjustment highlights the inherent execution risks within the quantum industry. Scaling systems to higher qubit counts does not present a linear increase in complexity—technical hurdles, like those with the tunable couplers, can disrupt entire project timelines.

Rigetti’s 108-qubit machine is itself an intermediate step toward a more ambitious long-term goal: developing a system with over 1,000 qubits by 2027. As these targets become more advanced, the credibility of each milestone grows in importance.

A fundamental challenge remains: converting technical achievements into predictable revenue streams. Rigetti is not yet profitable, leading investors to scrutinize whether technological progress will translate into a sustainable business model.

Market sentiment is further contextualized by a report dated January 14, which noted net insider selling across several quantum computing stocks over the past three years, including Rigetti. Such activity fuels debate over whether current valuations appropriately reflect future potential or have run ahead of reality.

The stock’s price action reflects this blend of opportunity and uncertainty, exhibiting considerable volatility. While recently trading at $24.47—approximately 22% above its level from 30 days prior—the equity remains notably below its 52-week high.

Key Upcoming Milestones for Shareholders

Two forthcoming dates are particularly critical for investor assessment. The first is the end of Q1 2026, the new target for the Cepheus‑1‑108Q system’s general availability. This will serve as a practical test of the updated roadmap. The second is the next quarterly earnings report, anticipated between March 6 and 12, 2026. Management is expected to provide greater detail on how the revised timeline impacts revenue projections, cost structure, and the long-term plan for systems exceeding 1,000 qubits.

Ad

Rigetti Stock: Buy or Sell?! New Rigetti Analysis from February 7 delivers the answer:

The latest Rigetti figures speak for themselves: Urgent action needed for Rigetti investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Rigetti: Buy or sell? Read more here...

Tags: Rigetti
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
Amazon Stock

Amazon Appeals Italian Antitrust Ruling Despite Fine Reduction

FactSet Research Stock

FactSet Research: Strong Earnings Fail to Convince Skeptical Analyst

Parker-Hannifin Stock

Parker-Hannifin Shares Attract Bullish Price Target Revisions

Recommended

MDB stock news

Insider Trading Activity and Institutional Investment in MongoDB, Inc.: Key Developments to Monitor for Shareholders

3 years ago
Paramount Global Stock

Paramount Global Initiates Major Workforce Reduction Following Merger

3 months ago
Coinbase Stock

Coinbase Bets on Prediction Markets Amid Crypto Uncertainty

3 months ago
Nvidia Stock

Nvidia’s Strategic Gambits Fuel Market Speculation

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Trending

Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

by Jackson Burston
February 7, 2026
0

A strategic acquisition in Texas is proving to be a significant catalyst for Guaranty Bancshares. The bank's...

Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy
  • ServiceNow Shares Face Market Skepticism Despite Record Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com